4//SEC Filing
Angelino Mark D. 4
Accession 0000899243-20-022713
CIK 0001733294other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 4:07 PM ET
Size
8.1 KB
Accession
0000899243-20-022713
Insider Transaction Report
Form 4
Angelino Mark D.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2020-08-14$0.60/sh+62,560$37,536→ 345,637 total - Exercise/Conversion
Stock Option (right to buy)
2020-08-14−62,560→ 37,536 totalExercise: $0.60Exp: 2028-01-04→ Common Stock (62,560 underlying)
Holdings
- 169,846(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The securities are directly held by the Mark D. Angelino 2020 Qualified Annuity Trust, or the Trust. Mark D. Angelino is the settlor and trustee of the Trust, and the Trust is for the benefit of Elizabeth I., Emily A., John P., and Matthew R. Angelino. The reporting person may be deemed to beneficially own the shares of common stock owned by the Trust.
- [F2]The option to purchase 100,096 shares was granted on January 5, 2018. The shares underlying the option vest over four years, with 25% of the shares vested on January 5, 2019 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0001814308
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 4:07 PM ET
- Size
- 8.1 KB